Blood Phoenixin-14 Levels and Echocardiographic Findings in Infants of Diabetic Mothers

NARecruitingINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

October 1, 2025

Study Completion Date

October 1, 2025

Conditions
Newborn MorbidityNewborn Complication
Interventions
DIAGNOSTIC_TEST

echocardiographic evaluation and blood phoenixin-14 level

For participants who provide consent, blood samples will be collected at 6 hours postpartum. Additionally, infants included in the study will undergo an echocardiographic evaluation by a pediatric cardiologist between postnatal days 3 and 5.

Trial Locations (1)

42020

RECRUITING

Melek Buyukeren, Konya

All Listed Sponsors
lead

Konya City Hospital

OTHER